Blood endotoxin levels were increased among patients with nonalcoholic fatty liver disease compared with healthy controls and may serve as a relevant diagnostic biomarker, according to research in Clinical Gastroenterology and Hepatology.
“NAFLD is asymptomatic during early development, thus hindering early disease detection. Moreover, even during progression of the disease, noninvasive diagnostic tools for a reliable diagnosis and disease staging are lacking,” Josefin Soppert, MS, a PhD candidate at the Institute for Molecular Cardiovascular Research at University Hospital RWTH